CClinicalTrials.gg
CompletedNCT05129293TPMIUpdated Oct 18, 2024Results posted

Improving Prospective Memory Via Telehealth

An interventional study of Prospective Memory Intervention and Educational in Multiple Sclerosis, sponsored by Trinity Health Of New England. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-10-18.

Sponsored by Trinity Health Of New England · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Up to 70% of persons with multiple sclerosis (PwMS) experience cognitive impairment, which can have a significant impact on several aspects of their daily lives. One cognitive domain that has been shown to impact daily functioning, but is understudied in MS, is prospective memory (PM). While there have been successful PM interventions in other clinical populations, to date there has not been a specific PM intervention for PwMS that has been tested in a clinical trial.

The study will be a double-masked randomized feasibility trial, with 18 participants randomized to a PM intervention and 18 participants randomized to an active control (psychoeducation). Participants will meet with an interventionist twice a week for four weeks. Feasibility will be assessed via 1) recruitment, enrollment, and retention; 2) adherence to the treatment; 3) treatment credibility and expectancy; and 4) treatment satisfaction. A preliminary effect size (Cohen's d) will be computed for the group difference using participants' performance on the Memory for Intentions Test, which will be given at baseline (week 1) and post-treatment (week 6). Participants will also complete a battery of neuropsychological measures as part of their baseline and post-treatment assessments.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • prospective memory
  • cognitive dysfunction
  • multiple sclerosis
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's enrollment of 35 is below the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Trinity Health Of New England is the lead sponsor of 19 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinical diagnosis of MS
  • Able to read, write, and speak in English
  • Between the ages of 18 and 60
  • All genders
  • No history of other serious neurologic or psychiatric illness, including drug or alcohol misuse
  • No relapses within the past two months
  • Access to the Internet and a web camera
  • Not enrolled in a cognitive rehabilitation program within the past six months
  • Self-reported issues "remembering places they have to be" and "things they have to do"

Exclusion criteria

Exclusion Criteria:

  • No diagnosis of MS
  • Unable to complete the study protocol due to language barriers
  • Younger than 18 or older than 61
  • No gender exclusions
  • History of other serious neurologic or psychiatric illness, including drug or alcohol misuse
  • Had a relapse within the past two months
  • No access to the Internet and/or a web camera
  • Currently enrolled or enrolled in a cognitive rehabilitation program within the past six months
  • No self-reported issues with "remembering places they have to be" or "things they have to do"
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Prospective Memory Intervention

    Participants randomized to the PM intervention (active group) will meet with an interventionist twice a week for four weeks. The first four sessions will focus on visual imagery, while the last four sessions will focus on implementation intentions. Participants will be led through a manualized treatment.

    Behavioral: Prospective Memory Intervention

  • Active comparator
    Educational

    The control group (Education) will meet with a research assistant for the same frequency of sessions and will receive psychoeducation on MS and cognitive functioning. The interventionists will be following a manual and accompanying PowerPoint slides.

    Behavioral: Educational

Interventions

  • BehavioralProspective Memory Intervention

    Cognitive remediation focusing on prospective memory

  • BehavioralEducational

    Psychoeducation

06

What researchers measure

Primary outcomes

  1. Memory for Intentions Test Total Score Percentile

    Performance on objective prospective memory (overall performance). The MIST Total Score is calculated by summing the raw scores from the six subscales, which is transformed into percentiles using age- and education-stratified normative data. Scores ranged from \<1 9 (coded as 0 for analyses) to \>99 (coded as 100 for analyses), with higher scores indicating better prospective memory performance.

    Time frame: Six weeks

  2. Memory for Intentions Test Time Cue Subscale Percentile

    Performance on objective prospective memory (time-based)

    Time frame: Six weeks

Secondary outcomes

  1. Perceived Deficits Questionnaire-Prospective Memory Subscale

    Subjective prospective memory. The five items in the subscale are summed, with scores ranging between 0 and 20. Higher scores indicate more subjective prospective memory issues.

    Time frame: Six weeks

07

Results

Posted Oct 18, 2024

Participant flow

Participant flow — Overall Study
MilestoneProspective Memory InterventionEducational
Started1718
Completed1516
Not completed22

Outcome measures

PrimaryMemory for Intentions Test Total Score Percentile

Performance on objective prospective memory (overall performance). The MIST Total Score is calculated by summing the raw scores from the six subscales, which is transformed into percentiles using age- and education-stratified normative data. Scores ranged from \<1 9 (coded as 0 for analyses) to \>99 (coded as 100 for analyses), with higher scores indicating better prospective memory performance.

Time frame:
Six weeks
Reported as:
Mean · Percentile
Memory for Intentions Test Total Score Percentile
PercentileProspective Memory InterventionEducational
Baseline32.24 ± 21.7838.94 ± 24.29
Post-Treatment35.02 ± 22.7745.40 ± 36.62
Statistical analysis
  • Prospective Memory Intervention vs Educational · ANCOVA · p = 0.229Adjusted for disease duration, SymptoMScreen depression and anxiety scores, and Test of Everyday Cognition baseline performance
PrimaryMemory for Intentions Test Time Cue Subscale Percentile

Performance on objective prospective memory (time-based)

Time frame:
Six weeks
Reported as:
Mean · Percentile
Memory for Intentions Test Time Cue Subscale Percentile
PercentileProspective Memory InterventionEducational
Baseline35.00 ± 19.7551.78 ± 24.09
Post-treatment57.89 ± 30.5359.52 ± 29.89
Statistical analysis
  • Prospective Memory Intervention vs Educational · ANCOVA · p = 0.040Adjusted for disease duration, SymptoMScreen depression and anxiety scores, and Test of Everyday Cognition baseline performance
SecondaryPerceived Deficits Questionnaire-Prospective Memory Subscale

Subjective prospective memory. The five items in the subscale are summed, with scores ranging between 0 and 20. Higher scores indicate more subjective prospective memory issues.

Time frame:
Six weeks
Reported as:
Mean · score on a scale
Perceived Deficits Questionnaire-Prospective Memory Subscale
score on a scaleProspective Memory InterventionEducational
Baseline10.18 ± 2.708.44 ± 2.55
Post-Treatment8.79 ± 2.608.30 ± 2.74
Statistical analysis
  • Prospective Memory Intervention vs Educational · ANCOVA · p = 0.266Adjusted for disease duration, SymptoMScreen depression and anxiety scores, and Test of Everyday Cognition baseline performance

Adverse events

Collected over Six weeks. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Prospective Memory Intervention0/17 (0%)0/17 (0%)0/17 (0%)
Educational0/18 (0%)0/18 (0%)0/18 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Prospective Memory InterventionEducationalTotal
Mean47.29 ± 9.1548.17 ± 9.847.74 ± 9.37
Sex: Female, Male
Sex: Female, Male(Participants)Prospective Memory InterventionEducationalTotal
Female151631
Male224
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Prospective Memory InterventionEducationalTotal
Hispanic or Latino246
Not Hispanic or Latino151429
Unknown or Not Reported000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Prospective Memory InterventionEducationalTotal
Race — White121628
Race — Black314
Race — Multi-racial/Other213
08

Study locations

1 site
  • Mount Sinai Rehabilitation Hospital
    Hartford, Connecticut 06112, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jan 3, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05129293
Lead sponsor
Trinity Health Of New England
Responsible party
Sponsor
First posted
Nov 22, 2021
Start date
Nov 1, 2021
Primary completion
Jun 5, 2023
Completion
Jun 30, 2023
Results posted
Oct 18, 2024
Last update
Oct 18, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion